|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Agent 10/24/14 IMS Health Holdings, Inc. 8-K:2,9 10/24/14 2:174K Business Wire/FA |
Document/Exhibit Description Pages Size 1: 8-K Ims Health Holdings, Inc. 8-K HTML 14K 2: EX-99.1 Miscellaneous Exhibit HTML 98K
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
DC 20549
FORM 8-K
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15(d) OF THE
SECURITIES
EXCHANGE ACT OF 1934
October
24, 2014
Date
of report (date of earliest event reported)
|
IMS Health Holdings, Inc. |
|
(Exact name of registrant as specified in its charter) |
| Delaware | 001-36381 | 27-1335689 | ||
|
(State or other jurisdictions of
incorporation or organization) |
(Commission
File Number) |
(I.R.S. Employer
Identification Nos.) |
83 Wooster Heights Road
Danbury, CT 06810
(Address
of principal executive offices) (Zip Code)
(203) 448-4600
(Registrant’s telephone number, including
area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
⃞ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
⃞ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
⃞ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
⃞ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 2.02. Results of Operations and Financial Condition.
On October 24, 2014, the Company issued a press release regarding financial results for the third quarter ended September 30, 2014. A copy of this press release is being furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference into this Item 2.02.
In accordance with General Instruction B.2 of Form 8-K, the information in this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
|
Exhibit No. |
Description | |
| 99.1 | Press Release dated October 24, 2014 issued by IMS Health Holdings, Inc. |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| IMS HEALTH HOLDINGS, INC. | |||
| By: | /s/ Ronald E. Bruehlman | ||
| Name: | Ronald E. Bruehlman | ||
| Title: |
Senior Vice President &
Chief Financial Officer |
||
| This ‘8-K’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on / For Period End: | 10/24/14 | |||
| 9/30/14 | 10-Q | |||
| List all Filings | ||||